Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

February 2014 - FRMC

02/19/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—Preliminary results of a prospective, open-label, pilot trial showed that rituximab may be a safe and effective treatment option for patients with immunoglobulin G4-related disease (IgG4-RD), a multi-organ, fibro-inflammatory...
San Diego—Preliminary results of a prospective, open-label, pilot trial showed that rituximab may be a safe and effective treatment option for patients with immunoglobulin G4-related disease (IgG4-RD), a multi-organ, fibro-inflammatory...
San Diego—Preliminary results of...
02/19/2014
First Report Managed Care
02/19/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—For patients with hyperuricemia, urate-lowering therapy alone may not directly reduce the risk of kidney disease but may reduce other outcomes related to renal disease progression particularly in patients who achieve a serum acid of...
San Diego—For patients with hyperuricemia, urate-lowering therapy alone may not directly reduce the risk of kidney disease but may reduce other outcomes related to renal disease progression particularly in patients who achieve a serum acid of...
San Diego—For patients with...
02/19/2014
First Report Managed Care
02/19/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—For patients with early aggressive rheumatoid arthritis (RA), initial treatment with triple disease-modifying anti-rheumatic drug (DMARD) therapy is more cost-effective long-term than initial treatment with either an immediate or...
San Diego—For patients with early aggressive rheumatoid arthritis (RA), initial treatment with triple disease-modifying anti-rheumatic drug (DMARD) therapy is more cost-effective long-term than initial treatment with either an immediate or...
San Diego—For patients with...
02/19/2014
First Report Managed Care
02/19/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—In patients with early rheumatoid arthritis (RA), treatment with triple disease-modifying antirheumatic drug (DMARD) therapy was found superior to methotrexate monotherapy, even after 12 months of therapy. The superior benefit of...
San Diego—In patients with early rheumatoid arthritis (RA), treatment with triple disease-modifying antirheumatic drug (DMARD) therapy was found superior to methotrexate monotherapy, even after 12 months of therapy. The superior benefit of...
San Diego—In patients with early...
02/19/2014
First Report Managed Care
02/19/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—In patients with fibromyalgia on antidepressants for comorbid depression, treatment with pregabalin safely and effectively reduces pain severity, according to the first study to examine this combination of medications for...
San Diego—In patients with fibromyalgia on antidepressants for comorbid depression, treatment with pregabalin safely and effectively reduces pain severity, according to the first study to examine this combination of medications for...
San Diego—In patients with...
02/19/2014
First Report Managed Care
02/19/2014

Sarah O'Brien

Sarah O'Brien
A study of the adverse event rates among Medicare patients with common medical conditions discovered a decline in patients hospitalized for acute myocardial infarction (MI) or congestive heart failure (CHF), while no change was seen for...
A study of the adverse event rates among Medicare patients with common medical conditions discovered a decline in patients hospitalized for acute myocardial infarction (MI) or congestive heart failure (CHF), while no change was seen for...
A study of the adverse event...
02/19/2014
First Report Managed Care
02/19/2014

Kerri Fitzgerald

Kerri Fitzgerald
With the introduction of the Patient Protection and Affordable Care Act (ACA), the debate on universal healthcare has become heated. Cross-country analysis can examine health system structures and outcomes, providing information on how...
With the introduction of the Patient Protection and Affordable Care Act (ACA), the debate on universal healthcare has become heated. Cross-country analysis can examine health system structures and outcomes, providing information on how...
With the introduction of the...
02/19/2014
First Report Managed Care
02/19/2014

Sarah O'Brien

Sarah O'Brien
A recent study sought to determine the independent associations of coronary artery calcium (CAC) volume and CAC density with incident cardiovascular disease (CVD), including coronary heart disease (CHD) [JAMA. 2014;311(3):271-278]. CAC...
A recent study sought to determine the independent associations of coronary artery calcium (CAC) volume and CAC density with incident cardiovascular disease (CVD), including coronary heart disease (CHD) [JAMA. 2014;311(3):271-278]. CAC...
A recent study sought to...
02/19/2014
First Report Managed Care
02/19/2014

Mary Mihalovic

Mary Mihalovic
Many physicians greatly underestimate the amount of radiation patients are exposed to during the most commonly administered tests, according to a recent literature review [Eur Heart J. DOI:10.1093/eurheartj/eht394]. Increased awareness and...
Many physicians greatly underestimate the amount of radiation patients are exposed to during the most commonly administered tests, according to a recent literature review [Eur Heart J. DOI:10.1093/eurheartj/eht394]. Increased awareness and...
Many physicians greatly...
02/19/2014
First Report Managed Care
02/19/2014

Mary Mihalovic

Mary Mihalovic
An adhesive electrocardiographic (ECG) monitoring patch detected significantly more arrhythmias compared with the conventionally used Holter monitor, according to results from a recent study [Am J Med. 2014;127:95.e11-95.e17].
An adhesive electrocardiographic (ECG) monitoring patch detected significantly more arrhythmias compared with the conventionally used Holter monitor, according to results from a recent study [Am J Med. 2014;127:95.e11-95.e17].
An adhesive electrocardiographic...
02/19/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement